Our findings revealed a novel mechanistic link between macrophage reprogramming and neural invasion, positioning the SRC‐1/STAT1/MMP12 axis as a promising therapeutic target for mitigating PNI in pancreatic cancer. Here, MMP12 is linked to familial pancreatic carcinoma.